Related content

Peripheral blood lymphocyte/monocyte ratio predicts outcome for patients with diffuse large B cell lymphoma after standard first-line regimens

By Li Yan-Li   Pan Yue-Yin   Jiao Yang   Ning Jie   Fan Yin-Guang   Zhai Zhi-Min  

Annals of Hematology, Vol. 93, Iss. 4, 2014-04 ,pp. : 617-626

Springer Publishing Company

Access to resources Recommend Favorite

Diffuse large B-cell lymphoma primary of lung

By Neri Natividad   Jesús Nambo M   Avilés Agustin  

Hematology, Vol. 16, Iss. 2, 2011-03 ,pp. : 110-112

Maney Publishing

Access to resources Recommend Favorite

Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement

By Lee Keun-Wook  

Annals of Hematology, Vol. 88, Iss. 9, 2009-09 ,pp. : 829-838

Springer Publishing Company

Access to resources Recommend Favorite

Clinical impact of bulky mass in the patient with primary extranodal diffuse large B cell lymphoma treated with R-CHOP therapy

By Song Moo-Kon   Chung Joo-Seop   Sung-Yong Oh   Lee Gyeong-Won   Kim Seung-Geun   Seol Young-Mi   Shin Ho-Jin   Choi Young-Jin   Cho Goon-Jae   Shin Dong-Hoon   Yun Eun-Young  

Annals of Hematology, Vol. 89, Iss. 10, 2010-10 ,pp. : 985-991

Springer Publishing Company

Access to resources Recommend Favorite

Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP

By Bosly A.  

Annals of Hematology, Vol. 87, Iss. 4, 2008-04 ,pp. : 277-283

Springer Publishing Company

Access to resources Recommend Favorite